Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant.

Beyer CE, Lin Q, Platt B, Malberg J, Hornby G, Sullivan KM, Smith DL, Lock T, Mitchell PJ, Hatzenbuhler NT, Evrard DA, Harrison BL, Magolda R, Pangalos MN, Schechter LE, Rosenzweig-Lipson S, Andree TH.

Br J Pharmacol. 2009 May;157(2):307-19. doi: 10.1111/j.1476-5381.2009.00146.x. Epub 2009 Mar 26.

3.

Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?

Cremers TI, Wiersma LJ, Bosker FJ, den Boer JA, Westerink BH, Wikström HV.

Biol Psychiatry. 2001 Jul 1;50(1):13-21.

PMID:
11457419
5.
6.

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.

Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57.

PMID:
15740724
7.

Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.

Zhang H, Wang W, Jiang Z, Shang J, Zhang L.

Arzneimittelforschung. 2010;60(3):109-15. doi: 10.1055/s-0031-1296258.

PMID:
20422941
8.

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC.

J Pharmacol Exp Ther. 2000 Aug;294(2):688-700.

9.

Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.

Bosker FJ, Folgering JH, Gladkevich AV, Schmidt A, van der Hart MC, Sprouse J, den Boer JA, Westerink BH, Cremers TI.

J Neurochem. 2009 Mar;108(5):1126-35. doi: 10.1111/j.1471-4159.2008.05850.x. Epub 2009 Jan 23.

10.

5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.

De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.

Eur Neuropsychopharmacol. 2004 Dec;14(6):487-95.

PMID:
15589388
11.

Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.

Pilar-Cuéllar F, Vidal R, Pazos A.

Br J Pharmacol. 2012 Feb;165(4b):1046-57. doi: 10.1111/j.1476-5381.2011.01516.x.

12.

Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.

Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.

J Med Chem. 2002 Sep 12;45(19):4128-39.

PMID:
12213056
13.

Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.

Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E.

J Pharm Pharmacol. 2003 Apr;55(4):533-43.

PMID:
12803776
15.

5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.

Sprouse J, Braselton J, Reynolds L.

Biol Psychiatry. 2000 Jun 15;47(12):1050-5.

PMID:
10862804
16.

Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.

Zazpe A, Artaiz I, Labeaga L, Lucero ML, Orjales A.

Neuropharmacology. 2007 Mar;52(3):975-84. Epub 2006 Dec 4.

PMID:
17141811
18.

Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.

Tordera RM, Monge A, Del Río J, Lasheras B.

Eur J Pharmacol. 2002 May 3;442(1-2):63-71.

PMID:
12020683
19.
20.

Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.

Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.

Br J Pharmacol. 2010 Aug;160(8):1929-40. doi: 10.1111/j.1476-5381.2010.00738.x.

Supplemental Content

Support Center